Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries
- PMID: 8222108
- DOI: 10.1161/01.cir.88.5.2139
Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries
Abstract
Background: It has been shown that there is impairment of the vasodilatory response to acetylcholine in patients with hypercholesterolemia and angiographically normal coronary arteries. Moreover, in patients with angiographically smooth coronary arteries, the number of coronary risk factors is associated with a loss of endothelium-dependent vasodilation. The purpose of the present analysis was to evaluate in patients with and without coronary artery disease coronary vasomotor response to dynamic exercise in angiographically normal and stenosed coronary arteries and to relate the response to serum cholesterol levels as well as to other coronary risk factors.
Methods and results: Luminal area change during exercise (delta-ex, percent change compared with rest = 100%) was determined by biplane quantitative coronary arteriography in three groups: Group 1 consisted of 14 patients with normal total serum cholesterol of < 200 mg/100 mL; mean, 173 mg/100 mL (mean age, 51 years). Group 2 comprised 23 patients with a slightly elevated cholesterol of 200 to 250 mg/100 mL; mean, 223 mg/100 mL (mean age, 53 years). Group 3 had 24 patients with markedly elevated cholesterol of > 250 mg/100 mL; mean, 288 mg/100 mL (mean age, 54 years). Serum cholesterol levels and categorical risk factors such as positive family history, history of hypertension, smoking, obesity, and diabetes were related to exercise-induced vasomotor response. The three groups did not differ with regard to clinical characteristics, exercise work load, and hemodynamic data measured during exercise. However, delta-ex in normal vessels was significantly different between all three groups (ANOVA, P < .01): +31% (group 1), +18% (group 2), and +4% (group 3). Delta-ex in stenotic vessels did not differ between the groups: -5% (group 1), -13% (group 2), and -12% (group 3). Delta-ex of the nonstenosed vessel correlated significantly and inversely with total cholesterol, with low-density lipoprotein cholesterol, with the ratio of total to high-density lipoprotein cholesterol, and with the number of coronary risk factors present in a patient. High total cholesterol and a history of hypertension were independent risk factors for impaired coronary vasomotion.
Conclusions: In patients with and without coronary artery disease, hypercholesterolemia and a history of hypertension independently impair exercise-induced coronary vasodilation in angiographically normal coronary arteries. In the stenotic vessel, vasomotion during exercise does not appear to be influenced by the actual serum cholesterol. The precise mechanism by which the impaired vasomotion of the angiographically normal coronary arteries is mediated is unknown, but a direct negative effect of hypercholesterolemia on endothelial function or early undetected atherosclerosis appears to be the most likely explanation.
Similar articles
-
Coronary risk factors, endothelial function, and atherosclerosis: a review.Clin Cardiol. 1997 May;20(5):426-32. doi: 10.1002/clc.4960200505. Clin Cardiol. 1997. PMID: 9134272 Free PMC article. Review.
-
Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate.J Am Coll Cardiol. 1995 Dec;26(7):1615-22. doi: 10.1016/0735-1097(95)00379-7. J Am Coll Cardiol. 1995. PMID: 7594094
-
Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension.Circulation. 1996 Apr 1;93(7):1380-7. doi: 10.1161/01.cir.93.7.1380. Circulation. 1996. PMID: 8641027
-
Reversal of abnormal coronary vasomotion by calcium antagonists in patients with hypercholesterolemia.Circulation. 1998 Apr 14;97(14):1348-54. doi: 10.1161/01.cir.97.14.1348. Circulation. 1998. PMID: 9577945
-
Vasomotor effects of iodinated contrast media: just side effects?Curr Vasc Pharmacol. 2003 Oct;1(3):321-8. doi: 10.2174/1570161033476664. Curr Vasc Pharmacol. 2003. PMID: 15320478 Review.
Cited by
-
Estimation of coronary flow reserve: can SPECT compete with other modalities?J Nucl Cardiol. 2001 Sep-Oct;8(5):620-5. doi: 10.1067/mnc.2001.118121. J Nucl Cardiol. 2001. PMID: 11593228 No abstract available.
-
Methodological aspects of physical activity assessment in epidemiological studies.Eur J Epidemiol. 1998 Jan;14(1):63-70. doi: 10.1023/a:1007427831179. Eur J Epidemiol. 1998. PMID: 9517875 Review.
-
Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow?J Nucl Cardiol. 2007 May-Jun;14(3):380-97. doi: 10.1016/j.nuclcard.2007.04.006. J Nucl Cardiol. 2007. PMID: 17556173 Review.
-
Coronary risk factors, endothelial function, and atherosclerosis: a review.Clin Cardiol. 1997 May;20(5):426-32. doi: 10.1002/clc.4960200505. Clin Cardiol. 1997. PMID: 9134272 Free PMC article. Review.
-
The value of quantitative myocardial perfusion imaging with positron emission tomography in coronary artery disease.Herz. 1997 Apr;22(2):87-95. doi: 10.1007/BF03044307. Herz. 1997. PMID: 9134442 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical